期刊文献+

血浆N末端B型利钠肽原水平对急诊呼吸困难病人的应用价值 被引量:1

Application value of plasma NT-proBNP levels in the differentiation of emergency patients with dyspnea
下载PDF
导出
摘要 目的分析并评价血浆N末端B型利钠肽原(NT-proBNP)含量对急诊呼吸困难病人鉴别的应用价值。方法将我院急诊科自2012年3月至2013年11月期间收治的194例受检者分为心源性呼吸困难组110例与肺源性呼吸困难组84例。对两组患者的血浆NT-proBNP水平进行检测并检查心脏超声,对比分析两组患者的血浆NT-proBNP水平与左室射血分数;对心源性呼吸困难患者的血浆NT-proBNP水平与左室射血分数之间的相关性进行分析。结果心源性呼吸困难组患者的血浆NT-proBNP含量显著高于肺源性呼吸困难组患者(t=21.093,P=0.001),具有统计学意义;心源性呼吸困难组患者的LVEF水平显著低于肺源性呼吸困难组(t=18.093,P=0.001),具有统计学意义。心源性呼吸困难组患者的血浆NT-proBNP水平与LVEF之间呈负相关关系(r=-0.59,P<0.01)。结论血浆NT-proBNP水平在急性呼吸困难患者的诊断方面具有重要的应用价值。 Objective To analyze and evaluate the levels of plasma NT-proBNP in the differentiation of emergency patients with dyspnea. Methods 194 patients were divided into the cardiac dyspnea group( 110 cases)and the pulmonary dyspnea group( 84 cases). The level of plasma NT-proBNP was detected and they were also given heart ultrasound. The relationship between plasma NT-proBNP level and left ventricular ejection fraction was analyzed. Results The level of plasma NT-proBNP was obviously higher in the cardiac dyspnea group than in the pulmonary dyspnea group( t = 21. 093,P = 0. 001). The level of LVEF was obviously lower in the cardiac dyspnea group than in the pulmonary dyspnea group( t = 18. 093,P = 0. 001). There was a negative correlation between the level of plasma NT-proBNP and LVEF in patients with cardiogenic dyspnea( r =- 0. 59,P〈0. 01). Conclusion The level of plasma NT-proBNP has important application value in the diagnosis of patients with acute dyspnea.
出处 《临床肺科杂志》 2014年第10期1810-1813,共4页 Journal of Clinical Pulmonary Medicine
关键词 N端脑钠肽前体 心源性呼吸困难 肺源性呼吸困难 左室射血分数 N terminal pro brain natriuretic peptide(NT-proBNP) cardiac dyspnea dyspnea left ventric-ular ejection fraction
  • 相关文献

参考文献13

  • 1王伟佳,张秀明,王前,温冬梅,欧阳能良,崔亚丽,李飞.心力衰竭时N末端B型利钠肽原与B型利钠肽检测时受干扰的分析[J].中华心血管病杂志,2011,39(8):695-699. 被引量:23
  • 2Rosiak M, Postula M, Kaplon-Cieslicka A, et al. Metformin treat- ment may be associated with decreased levels of NT-proBNP in pa- tients with type 2 diabetes[J]. Adv Med Sci, 2013, 10( 1 ) : 12 -18.
  • 3Costantino G, Solbiati M, Casazza G, et al. Usefulness of N-ter- minal pro-B-type natriuretic Peptide increase as a marker for cardi- ac arrhythmia in patients with syncope[ J]. Am J Cardiol, 2014, 113(1) : 98 -102.
  • 4Humm K, Hezzell M, Sargent J, et al. Differentiating between fe- line pleural effusions of cardiac and non-cardiac origin using pleu- ral fluid NT-proBNP concentrations [ J ]. J Small Anim Pract, 2013, 54(12) :656 -661.
  • 5韦丙奇,张健,杨跃进,吕蓉,张宇辉,周琼,高润霖.N末端B型利钠肽原在陈旧性心肌梗死患者中诊断心力衰竭的价值[J].中华心血管病杂志,2012,40(1):34-38. 被引量:50
  • 6Tang Q, Liu M, Ma Z, et al. Non-invasive evaluation of hemody- namics in pulmonary hypertension by a Septal angle measured by computed tomography pulmonary angiography: Comparison with right-heart catheterization and association with N-terminal pro-B- type natriuretic peptide[ J]. Exp Ther Med, 2013, 6 (6) : 1350 - 1358.
  • 7Sahlen A, Wu E, Rack A, et al. Relation between N-terminal pro-brain natriuretic peptide leve|s and response to enhanced exter- nal counterpulsation in chronic angina pectoris [ J ]. Coron Artery Dis, 2014, 25(1) :45 -51.
  • 8王冬利.脑钠素在急诊呼吸困难鉴别诊断中的应用[J].临床肺科杂志,2010,15(2):183-184. 被引量:11
  • 9Salah K, Kok WE, Eurlings LW, et al. A novel discharge risk model for patients hospitalised for acute decompensated heart fail- ure incorporating N-terminal pro-B-type natriuretic peptide levels:a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score[J]. Heart, 2014, 100(2) :115 -125.
  • 10魏敦双.急性呼吸困难的病因分析和血浆N末端B型利钠肽原检测的应用价值[J].临床肺科杂志,2011,16(8):1236-1238. 被引量:7

二级参考文献31

  • 1汪芳,李卫,黄洁,王莉,边文彦,庞会敏,王洋,顼志敏,李一石.血浆N末端原脑利钠肽水平对慢性心力衰竭患者长期预后的预测价值[J].中华心血管病杂志,2006,34(1):28-32. 被引量:83
  • 2冯月娟,边双双,全龙娟,黄强,李旭.B型脑钠肽在慢性阻塞性肺病中的诊断价值[J].临床肺科杂志,2007,12(5):462-463. 被引量:21
  • 3Ang DS, Kong CF, Kao Mp, et al. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities. Am Heart J,2009,158 (1) :133 -140.
  • 4Cowie MR, Mendez GF. BNP and congestive heart failure. Prog Cardiovasc Dis,2002,44(4) :293 -321.
  • 5郑松柏,黄福达,张秀明.精密度性能评价//杨有业,张秀明.临床检验方法学评价.北京:人民卫生出版社,2009:98-117.
  • 6徐建华,余元龙.分析于扰性能评价//杨有业,张秀明.临床检验方法学评价.北京:人民卫生出版社,2009:196-234.
  • 7Abelardo MR,Richards AM,Jone CB,et al.Biology of the natriuretic peptides.Am J Cardiol,2008,101:S3-S8.
  • 8Giuseppe L,Antonio F,Gian LS,et al.Influence of sample matrix and storage on BNP measurement on the Bayer Advia Centaur.J Clinical Laboratory Analysis,2007,21:293-297.
  • 9Giuseppe L,Gian LS,Martina M,et al.Measurement of Elecsys NT-proBNP in serum,K2 EDTA and heparin plasma.Clinical Biochemistry,2007,40:747-748.
  • 10Kiang JY,Alan HB,Fred SA,et al.Multicenter evaluation of the Roche NT-proBNP assay and comparison to the biosite triage BNP assay.Clinica Chimica Acta,2003,338:107-115.

共引文献77

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部